key: cord-0847428-9ymyeysy authors: Seeliger, Barbara; Philouze, Guillaume; Benotmane, Ilies; Mutter, Didier; Pessaux, Patrick title: Is the SARS-CoV-2 virus present intraperitoneally in patients with COVID infection undergoing emergency operations? date: 2020-06-05 journal: Surgery DOI: 10.1016/j.surg.2020.05.033 sha: 82209bc9a52cb658f82a39967535bc7a2fbf5a3b doc_id: 847428 cord_uid: 9ymyeysy nan In COVID-19 patients, there is a high incidence of gastrointestinal (GI) complications including ischemia 1 . Moreover, the pooled presence of RNA from the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in symptomatic patients was found to be 54% in fecal samples 2 . Little evidence, however, is available on potential intra-abdominal presence of the virus. Protective measures to minimize staff exposure are recommended by surgical societies worldwide, such as the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) and the European Association for Endoscopic Surgery (EAES) 3 . The need to determine whether SARS-CoV-2 is present in abdominal fluids or aerosols originating from carbon dioxide insufflation has been stated. The present study aimed to determine if the SARS-CoV-2 virus was present intraoperatively within the peritoneal fluid in a series of COVID-19 patients undergoing emergency abdominal surgery. COVID-19 patients undergoing an operative procedure were included in a prospective database within the framework of the CovidSurg international multi-centric cohort study (NCT04323644, French national approval by the CHU Rennes ethical committee on March 20, 2020, #20.25). All patients had pulmonary involvement of some extent (table 1) Table 1 . Peritoneal fluid was sampled intraoperatively and analyzed at the virology laboratory of the University of Strasbourg. Gene amplification was performed via reverse transcriptase-polymerase chain reaction (RT-PCR) using the in-house assay, which targets two regions of SARS-CoV-2 RNA-dependent RNA polymerase (RdRp) gene according to the technical guidance of the Institut Pasteur protocol and the World Health Organization (WHO) 4 . The threshold limit of detection is 10 copies per reaction. In five patients, the sample quantity was sufficient for RT-PCR analysis. Two patients required immediate operative intervention at admission, recovered well, and were discharged on POD 4 and POD 3 respectively. Three patients critically ill from their COVID infection developed an acute abdomen during hospitalization and are still being treated in the intensive care unit. The peritoneal samples were obtained both at the beginning and at the end of the operation in 3 patients and only at the beginning in 2 patients. Intraperitoneal SARS-CoV-2 infection was not detectable on RT-PCR in any of these patients. The cell membrane protein angiotensin-converting enzyme 2 (ACE2) is key for receptormediated cell entry of SARS-CoV-2. ACE2 is not only expressed in pneumocytes (type II alveolar cells), but also in the GI tract, notably in ileal and colonic enterocytes 5 . During a COVID-19 infection, the GI tract could be injured directly via virus entry into enterocytes or indirectly via the host inflammatory response 6 . RT-PCR is the gold standard for testing for acute illness, and in the present study, no intraperitoneal contamination/shedding was observed. Although based on this low number of cases (n=5), the risk of intraperitoneal contamination/shedding of virus seems less than might be suspected. Intraabdominal aerosol production generated from the peritoneal fluid via insufflation of the carbon dioxide peumoperitoneum or from smoke generated by cauterization causing potential spread of the virus to the OR staff or the systemic spread of the virus from the lungs to other organs and body cavities might be less common than reported for other viruses (Further research is necessary to elucidate the mechanisms of a COVID-19 associated pathology in the GI tract, in order to identify potential preventive treatment options and optimal protective strategies for the operating room personnel. Despite the absence of detection of intraperitoneal viral RNA in these 5 patients, caution is required to mitigate any potential infection of the operating room team. Currently, there is no sufficient evidence to decrease protective measures whether performing laparoscopy or open abdominal surgery. Rectosigmoidoscopy found ulcerative and ischemic changes, representing an indication for operative intervention without need for a CT. **#5: The patient had a lumbar incision 3 days earlier to evacuate a left retroperitoneal bleeding/hematoma refractory to arterial embolization. After reduction of the incarcerated bowel, she needed a vacuum laparotomy closure for abdominal compartment syndrome. Small bowel ischemia and SARS-CoV-2 infection: an underdiagnosed distinct clinical entity Manifestations and prognosis of gastrointestinal and liver involvement in patients with COVID-19: a systematic review and meta-analysis SAGES and EAES recommendations for minimally invasive surgery during COVID-19 pandemic World Health Organization. Molecular assays to diagnose COVID-19: Summary table of available protocols Covid-19 and the digestive system Gastrointestinal, hepatobiliary, and pancreatic manifestations of COVID-19 The authors would like to thank Guy Temporal, professional in medical English, for his assistance in proofreading the manuscript.Author contributions: All authors participated in study conception and design, data collection, analysis and interpretation, manuscript drafting and revision. BS and GP equally contributed to this study. All authors critically reviewed and approved the final report.